“arthritis” Archives

Entry Author Date Location
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Crealta Spins Struggling Arthritis Drug Into $510M Horizon Payday 12/14/15 Wisconsin
Health IT Marketer eRelevance Plans Fundraising for Expansion 03/02/15 Texas
Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment 01/15/14 Boulder/Denver
Flexion Overhaul Bears Fruit With Upbeat Data From Arthritis Trial 05/30/12 Boston
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy 09/08/11 San Francisco
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients 11/09/10 San Diego
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior 09/20/10 Boston
It’s Time for Universities to Get More Nimble 09/02/10 San Francisco
Logical Therapeutics Snags $10M to Make Pain Relievers Safer on the Gut 05/21/10 Boston
Alder’s Long-Awaited Arthritis Data, Ikaria Plots $200M IPO, Emerald’s Resurrection, & More Seattle-Area Life Sciences News 05/20/10 Seattle
Roche, Biogen Halt Arthritis Study 03/08/10 Boston
Genomic Advances of the 2000s Will Demand an Informatics Revolution in the 2010s 01/14/10 National
It’s About Health Care, Not Health Insurance 09/28/09 Seattle
ConforMIS Shapes Corporate Expansion with $50M D Round 07/13/09 Boston
KaloBios Gets $12M Genzyme, Baxter 12/22/08 Boston
Alder Gets Early Christmas Present: FDA Slaps Down Its Rival, Roche 12/08/08 Seattle
Korean Biotech Opens Mass. Office 12/04/08 Boston
CombinatoRx Cuts 30 More Jobs, Wiping out Two-Thirds of Staff in Last Month 11/20/08 Boston
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says 11/13/08 Boston
CombinatoRx Cuts 45 Percent of Staff After Arthritis Drug Failure 11/04/08 Boston
Trubion Shares Leap, Drop, Leap Again After Encouraging Clinical Trial News 10/27/08 Seattle
ZymoGenetics Drug Trial Halted Because of Infection Risk 10/27/08 Seattle
ZymoGenetics Gets $21M From Bristol-Myers To Settle Patent Suit 10/23/08 Seattle
CombinatoRx Reckoning Arrives: Stock Crashes on Failed Arthritis Trial 10/06/08 Boston
CombinatoRx Judgment Day Coming Soon, Arthritis Drug Results On the Way 09/30/08 Boston
Ariad Loses Patent Case Against Amgen 09/22/08 Boston
Alder Sets Stage for Showdown With Roche, With “Fast Follower” Antibody Drug Strategy 09/18/08 Seattle
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors 08/26/08 Seattle
Page 1 of 2 next page »